NO20025901L - Antipyretisk preparat inneholdende xylitol - Google Patents

Antipyretisk preparat inneholdende xylitol

Info

Publication number
NO20025901L
NO20025901L NO20025901A NO20025901A NO20025901L NO 20025901 L NO20025901 L NO 20025901L NO 20025901 A NO20025901 A NO 20025901A NO 20025901 A NO20025901 A NO 20025901A NO 20025901 L NO20025901 L NO 20025901L
Authority
NO
Norway
Prior art keywords
preparation containing
antipyretic
containing xylitol
antipyretic preparation
xylitol
Prior art date
Application number
NO20025901A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025901D0 (no
Inventor
Daniel Wils
Roselyne Bernard
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of NO20025901D0 publication Critical patent/NO20025901D0/no
Publication of NO20025901L publication Critical patent/NO20025901L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20025901A 2001-12-10 2002-12-09 Antipyretisk preparat inneholdende xylitol NO20025901L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0115917A FR2833173B1 (fr) 2001-12-10 2001-12-10 Preparation antipyretique renfermant du xylitol

Publications (2)

Publication Number Publication Date
NO20025901D0 NO20025901D0 (no) 2002-12-09
NO20025901L true NO20025901L (no) 2003-06-11

Family

ID=8870281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025901A NO20025901L (no) 2001-12-10 2002-12-09 Antipyretisk preparat inneholdende xylitol

Country Status (10)

Country Link
US (2) US20030109565A1 (ja)
EP (1) EP1317922B1 (ja)
JP (1) JP2003171266A (ja)
CN (1) CN1432357A (ja)
AT (1) ATE359770T1 (ja)
CA (1) CA2413024A1 (ja)
DE (1) DE60219578D1 (ja)
FR (1) FR2833173B1 (ja)
MX (1) MXPA02012232A (ja)
NO (1) NO20025901L (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048358A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial substrates
US20070048344A1 (en) * 2005-08-31 2007-03-01 Ali Yahiaoui Antimicrobial composition
US20070048356A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial treatment of nonwoven materials for infection control
JP2008266203A (ja) * 2007-04-19 2008-11-06 Bussan Food Science Kk 活性酸素種消去酵素群の活性を向上させる方法
IL206739A (en) * 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833M (ja) * 1962-06-12 1964-10-05 I N I C O Ind Nuclear Invest C
GB1212115A (en) * 1967-11-29 1970-11-11 Far Eastern Detailers Ltd Pharmaceutical composition comprising magnesium acetylsalicylate and method for preparing same
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
DE69727922T2 (de) * 1996-04-16 2005-01-20 Novartis Consumer Health S.A. Schnell zerfallende orale dosierungsform
US5719196A (en) * 1996-07-24 1998-02-17 Leiras Oy Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol
US6270790B1 (en) * 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US6447754B1 (en) * 2000-01-24 2002-09-10 Akpharma Inc. Oral rinse methods and compositions

Also Published As

Publication number Publication date
NO20025901D0 (no) 2002-12-09
ATE359770T1 (de) 2007-05-15
FR2833173A1 (fr) 2003-06-13
MXPA02012232A (es) 2005-06-06
US20060142254A1 (en) 2006-06-29
CN1432357A (zh) 2003-07-30
US20030109565A1 (en) 2003-06-12
FR2833173B1 (fr) 2004-08-27
DE60219578D1 (de) 2007-05-31
JP2003171266A (ja) 2003-06-17
CA2413024A1 (fr) 2003-06-10
EP1317922B1 (fr) 2007-04-18
EP1317922A1 (fr) 2003-06-11

Similar Documents

Publication Publication Date Title
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
NO20041270D0 (no) Farmasoytiske sammensetninger som innbefatter kolloidal silikondioksid
PL410219A1 (pl) Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
YU23599A (sh) Stabilizovani antihistaminski sirup
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
DK1300398T3 (da) Propan-1,3-dionderivat
MXPA02009773A (es) Derivados de indolin-2-ona y su uso como ligandos de receptores de ocitocina.
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
CA2347195A1 (en) Oral pharmaceutical compositions containing buprenorphin
NO20013060D0 (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
NO20034527L (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
CY1112057T1 (el) Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι
EP1607097A3 (en) Stabilized compositions containing an oxygen-labile agent
NO20025901D0 (no) Antipyretisk preparat inneholdende xylitol
CA2442210A1 (en) Aryl oxime-piperazines useful as ccr5 antagonists
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
DE50213012D1 (de) Polyamide-zusammensetzungen enthaltend antioxidantien
NO20034529D0 (no) 3,7-diazabicyklo(3,3,1) formuleringer samt antiarytmiforbindelser
EP0987266A4 (en) BIPHENYL DERIVATIVES AND MEDICAL PREPARATIONS
NO20034528L (no) 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser
WO2001070184A3 (en) A composition containing monoterpenes for topical oral administration
BR0213463A (pt) Composições farmacêuticas contendo macrólidos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application